Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
24/08/2026 07:18
BRIEF-SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO Aug 24 (Reuters) - SkinBioTherapeutics PLC SBTX.L:
SKINBIOTHERAPEUTICS - APPOINTMENT OF INTERIM CFO
SKINBIOTHERAPEUTICS - ANITA SLATER TO START AS INTERIM CFO WITH IMMEDIATE EFFECT
Source text: ID:nRSX8088Ra
Further company coverage: SBTX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company